ACE2 and fatty liver disease: In the present study, we found that ACE2 activator, diminazene aceturate (DIZE), stabilized atherosclerotic plaque and attenuated hepatic steatosis in apoE−/− mice by influencing macrophages polarization and taurine biosynthesis.